Patient Guide: Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05345561
Status: ACTIVE_NOT_RECRUITING
Condition: Fetal and Neonatal Alloimmune Thrombocytopenia
Phase: Research Study

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Chandler, Arizona
  • • Gardena, California
  • • New Haven, Connecticut
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia - Join Clinical Trial NCTNCT05345561

How to Join This Clinical Trial - NCTNCT05345561

Learn how to participate in this clinical trial studying an investigational therapy for Fetal and Neonatal Alloimmune Thrombocytopenia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Fetal and Neonatal Alloimmune Thrombocytopenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Fetal and Neonatal Alloimmune Thrombocytopenia
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05345561 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Chandler, Arizona 85224 - United States

Status: Contact for availability

Clinical Research Site

Gardena, California 90247 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33136 - United States

Status: Contact for availability

Clinical Research Site

Camden, New Jersey 08103 - United States

Status: Contact for availability

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: Contact for availability

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: Contact for availability

Clinical Research Site

Newark, New Jersey 07103 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10032 - United States

Status: Contact for availability

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Fetal and Neonatal Alloimmune Thrombocytopenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships